Dow Jones

39 150,33

0,04%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
HCW Biologics Inc (HCWB)
HCW Biologics Inc (HCWB) Actualités

HCWB

HCW Biologics (HCWB)

HCW Biologics Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:HCWB

1 2 3 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
17/06/2024	22h57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
17/06/2024	22h33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HCWB	HCW Biologics Inc
20/05/2024	22h36	Edgar (US Regulatory)	Form ARS/A - Annual Report to Security Holders: [Amend]	NASDAQ:HCWB	HCW Biologics Inc
15/05/2024	23h21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HCWB	HCW Biologics Inc
15/05/2024	22h39	GlobeNewswire Inc.	HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
15/05/2024	22h35	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:HCWB	HCW Biologics Inc
01/04/2024	22h10	GlobeNewswire Inc.	HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
27/02/2024	22h27	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:HCWB	HCW Biologics Inc
14/11/2023	13h00	GlobeNewswire Inc.	HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
08/11/2023	13h30	GlobeNewswire Inc.	Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting	NASDAQ:HCWB	HCW Biologics Inc
01/11/2023	12h30	GlobeNewswire Inc.	Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting	NASDAQ:HCWB	HCW Biologics Inc
06/09/2023	13h30	GlobeNewswire Inc.	HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023	NASDAQ:HCWB	HCW Biologics Inc
11/08/2023	13h00	GlobeNewswire Inc.	HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
10/08/2023	23h01	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:HCWB	HCW Biologics Inc
15/06/2023	23h17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:HCWB	HCW Biologics Inc
14/06/2023	23h02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:HCWB	HCW Biologics Inc
14/06/2023	13h30	GlobeNewswire Inc.	HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders	NASDAQ:HCWB	HCW Biologics Inc
09/05/2023	13h15	GlobeNewswire Inc.	HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
27/04/2023	22h26	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:HCWB	HCW Biologics Inc
27/04/2023	22h22	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:HCWB	HCW Biologics Inc
27/04/2023	13h40	GlobeNewswire Inc.	HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan	NASDAQ:HCWB	HCW Biologics Inc
13/04/2023	13h15	GlobeNewswire Inc.	HCW Biologics Poster Presentation at AACR Annual Meeting 2023	NASDAQ:HCWB	HCW Biologics Inc
03/04/2023	14h13	GlobeNewswire Inc.	A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases	NASDAQ:HCWB	HCW Biologics Inc
28/03/2023	22h35	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:HCWB	HCW Biologics Inc
28/03/2023	22h25	GlobeNewswire Inc.	HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
08/12/2022	13h55	GlobeNewswire Inc.	HCW Biologics Enters CRADA with National Cancer Institute	NASDAQ:HCWB	HCW Biologics Inc
07/12/2022	13h30	GlobeNewswire Inc.	HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ Platform	NASDAQ:HCWB	HCW Biologics Inc
14/11/2022	22h25	TipRanks	JonesTrading Keeps Their Buy Rating on HCW Biologics (HCWB)	NASDAQ:HCWB	HCW Biologics Inc
09/11/2022	19h15	TipRanks	Maxim Group Sticks to Its Buy Rating for HCW Biologics (HCWB)	NASDAQ:HCWB	HCW Biologics Inc
08/11/2022	13h00	GlobeNewswire Inc.	Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meeting	NASDAQ:HCWB	HCW Biologics Inc